Does the media prefer DUOT or DH?

In the previous week, Duos Technologies Group had 1 more articles in the media than Definitive Healthcare. MarketBeat recorded 3 mentions for Duos Technologies Group and 2 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 0.85 beat Duos Technologies Group's score of 0.79 indicating that Definitive Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Duos Technologies Group 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Definitive Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor DH or PERI?

In the previous week, Definitive Healthcare and Definitive Healthcare both had 2 articles in the media. Definitive Healthcare's average media sentiment score of 0.85 beat Perion Network's score of 0.74 indicating that Definitive Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Definitive Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Perion Network 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, ARQQ or DH?

Arqit Quantum has higher earnings, but lower revenue than Definitive Healthcare. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Arqit Quantum $530K 826.24 -$35.34M N/A N/A Definitive Healthcare $241.52M 0.33 -$138.93M -$1.62 N/A

Does the media prefer ARQQ or DH?

In the previous week, Arqit Quantum had 2 more articles in the media than Definitive Healthcare. MarketBeat recorded 4 mentions for Arqit Quantum and 2 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 0.85 beat Arqit Quantum's score of -0.08 indicating that Definitive Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Arqit Quantum 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Definitive Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Definitive Healthcare (DH) Competitors

$0.76 +0.02 (+3.09%)

Closing price 04:00 PM Eastern

Extended Trading

$0.78 +0.02 (+1.97%)

As of 05:44 PM Eastern

Compare

DH vs. DUOT, TLS, PERI, ISSC, and ARQQ

Should you buy Definitive Healthcare stock or one of its competitors? MarketBeat compares Definitive Healthcare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Definitive Healthcare include Duos Technologies Group (DUOT), Telos (TLS), Perion Network (PERI), Innovative Solutions and Support (ISSC), and Arqit Quantum (ARQQ). These companies are all part of the "computer software" industry.

How does Definitive Healthcare compare to Duos Technologies Group?

Duos Technologies Group (NASDAQ:DUOT) and Definitive Healthcare (NASDAQ:DH) are both small-cap computer software companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

Duos Technologies Group has higher earnings, but lower revenue than Definitive Healthcare. Duos Technologies Group is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Duos Technologies Group	$27.02M	12.31	-$9.84M	-$0.66	N/A
Definitive Healthcare	$241.52M	0.33	-$138.93M	-$1.62	N/A

In the previous week, Duos Technologies Group had 1 more articles in the media than Definitive Healthcare. MarketBeat recorded 3 mentions for Duos Technologies Group and 2 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 0.85 beat Duos Technologies Group's score of 0.79 indicating that Definitive Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Duos Technologies Group	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Definitive Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Duos Technologies Group has a net margin of -45.36% compared to Definitive Healthcare's net margin of -76.04%. Definitive Healthcare's return on equity of 4.04% beat Duos Technologies Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Duos Technologies Group	-45.36%	-21.46%	-15.66%
Definitive Healthcare	-76.04%	4.04%	1.99%

Duos Technologies Group currently has a consensus price target of $22.00, indicating a potential upside of 94.00%. Definitive Healthcare has a consensus price target of $2.77, indicating a potential upside of 264.04%. Given Definitive Healthcare's higher probable upside, analysts clearly believe Definitive Healthcare is more favorable than Duos Technologies Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Duos Technologies Group	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Definitive Healthcare	3 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.00

42.6% of Duos Technologies Group shares are owned by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are owned by institutional investors. 3.5% of Duos Technologies Group shares are owned by company insiders. Comparatively, 17.1% of Definitive Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Duos Technologies Group has a beta of 1.21, indicating that its stock price is 21% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.33, indicating that its stock price is 33% more volatile than the broader market.

Summary

Definitive Healthcare beats Duos Technologies Group on 10 of the 15 factors compared between the two stocks.

How does Definitive Healthcare compare to Telos?

Telos (NASDAQ:TLS) and Definitive Healthcare (NASDAQ:DH) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, earnings and dividends.

Telos currently has a consensus target price of $7.10, suggesting a potential upside of 63.59%. Definitive Healthcare has a consensus target price of $2.77, suggesting a potential upside of 264.04%. Given Definitive Healthcare's higher probable upside, analysts plainly believe Definitive Healthcare is more favorable than Telos.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Telos	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Definitive Healthcare	3 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.00

In the previous week, Definitive Healthcare had 1 more articles in the media than Telos. MarketBeat recorded 2 mentions for Definitive Healthcare and 1 mentions for Telos. Definitive Healthcare's average media sentiment score of 0.85 beat Telos' score of 0.00 indicating that Definitive Healthcare is being referred to more favorably in the news media.

Company	Overall Sentiment
Telos	Neutral
Definitive Healthcare	Positive

Telos has higher earnings, but lower revenue than Definitive Healthcare. Telos is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Telos	$164.80M	1.97	-$36.55M	-$0.35	N/A
Definitive Healthcare	$241.52M	0.33	-$138.93M	-$1.62	N/A

Telos has a net margin of -14.25% compared to Definitive Healthcare's net margin of -76.04%. Definitive Healthcare's return on equity of 4.04% beat Telos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Telos	-14.25%	-11.95%	-8.45%
Definitive Healthcare	-76.04%	4.04%	1.99%

62.1% of Telos shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 14.9% of Telos shares are held by company insiders. Comparatively, 17.1% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Telos has a beta of 0.97, indicating that its share price is 3% less volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.33, indicating that its share price is 33% more volatile than the broader market.

Summary

Definitive Healthcare beats Telos on 11 of the 17 factors compared between the two stocks.

How does Definitive Healthcare compare to Perion Network?

Definitive Healthcare (NASDAQ:DH) and Perion Network (NASDAQ:PERI) are both small-cap computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings, dividends and media sentiment.

Definitive Healthcare has a beta of 1.33, indicating that its share price is 33% more volatile than the broader market. Comparatively, Perion Network has a beta of 1.22, indicating that its share price is 22% more volatile than the broader market.

In the previous week, Definitive Healthcare and Definitive Healthcare both had 2 articles in the media. Definitive Healthcare's average media sentiment score of 0.85 beat Perion Network's score of 0.74 indicating that Definitive Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Definitive Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Perion Network	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Perion Network has a net margin of -2.17% compared to Definitive Healthcare's net margin of -76.04%. Definitive Healthcare's return on equity of 4.04% beat Perion Network's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Definitive Healthcare	-76.04%	4.04%	1.99%
Perion Network	-2.17%	3.34%	2.50%

98.7% of Definitive Healthcare shares are owned by institutional investors. Comparatively, 68.1% of Perion Network shares are owned by institutional investors. 17.1% of Definitive Healthcare shares are owned by insiders. Comparatively, 2.8% of Perion Network shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Perion Network has higher revenue and earnings than Definitive Healthcare. Perion Network is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Definitive Healthcare	$241.52M	0.33	-$138.93M	-$1.62	N/A
Perion Network	$439.93M	0.79	-$7.93M	-$0.25	N/A

Definitive Healthcare currently has a consensus price target of $2.77, suggesting a potential upside of 264.04%. Perion Network has a consensus price target of $13.88, suggesting a potential upside of 54.85%. Given Definitive Healthcare's higher possible upside, analysts clearly believe Definitive Healthcare is more favorable than Perion Network.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Definitive Healthcare	3 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.00
Perion Network	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Definitive Healthcare and Perion Network tied by winning 8 of the 16 factors compared between the two stocks.

How does Definitive Healthcare compare to Innovative Solutions and Support?

Definitive Healthcare (NASDAQ:DH) and Innovative Solutions and Support (NASDAQ:ISSC) are both small-cap computer software companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment and earnings.

Innovative Solutions and Support has a net margin of 18.82% compared to Definitive Healthcare's net margin of -76.04%. Innovative Solutions and Support's return on equity of 27.52% beat Definitive Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Definitive Healthcare	-76.04%	4.04%	1.99%
Innovative Solutions and Support	18.82%	27.52%	16.28%

Definitive Healthcare has a beta of 1.33, meaning that its share price is 33% more volatile than the broader market. Comparatively, Innovative Solutions and Support has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market.

98.7% of Definitive Healthcare shares are held by institutional investors. Comparatively, 28.5% of Innovative Solutions and Support shares are held by institutional investors. 17.1% of Definitive Healthcare shares are held by insiders. Comparatively, 5.9% of Innovative Solutions and Support shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Definitive Healthcare currently has a consensus price target of $2.77, suggesting a potential upside of 264.04%. Innovative Solutions and Support has a consensus price target of $16.25, suggesting a potential downside of 2.34%. Given Definitive Healthcare's higher probable upside, equities research analysts plainly believe Definitive Healthcare is more favorable than Innovative Solutions and Support.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Definitive Healthcare	3 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.00
Innovative Solutions and Support	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00

Innovative Solutions and Support has lower revenue, but higher earnings than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than Innovative Solutions and Support, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Definitive Healthcare	$241.52M	0.33	-$138.93M	-$1.62	N/A
Innovative Solutions and Support	$84.30M	3.53	$15.63M	$0.94	17.70

In the previous week, Definitive Healthcare had 1 more articles in the media than Innovative Solutions and Support. MarketBeat recorded 2 mentions for Definitive Healthcare and 1 mentions for Innovative Solutions and Support. Innovative Solutions and Support's average media sentiment score of 1.11 beat Definitive Healthcare's score of 0.85 indicating that Innovative Solutions and Support is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Definitive Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Innovative Solutions and Support	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Innovative Solutions and Support beats Definitive Healthcare on 10 of the 16 factors compared between the two stocks.

How does Definitive Healthcare compare to Arqit Quantum?

Arqit Quantum (NASDAQ:ARQQ) and Definitive Healthcare (NASDAQ:DH) are both small-cap computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

Arqit Quantum has a beta of 2.36, indicating that its stock price is 136% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.33, indicating that its stock price is 33% more volatile than the broader market.

In the previous week, Arqit Quantum had 2 more articles in the media than Definitive Healthcare. MarketBeat recorded 4 mentions for Arqit Quantum and 2 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 0.85 beat Arqit Quantum's score of -0.08 indicating that Definitive Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Arqit Quantum	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Definitive Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Arqit Quantum presently has a consensus target price of $60.00, suggesting a potential upside of 109.50%. Definitive Healthcare has a consensus target price of $2.77, suggesting a potential upside of 264.04%. Given Definitive Healthcare's higher possible upside, analysts plainly believe Definitive Healthcare is more favorable than Arqit Quantum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Arqit Quantum	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Definitive Healthcare	3 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.00

16.6% of Arqit Quantum shares are owned by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are owned by institutional investors. 54.6% of Arqit Quantum shares are owned by company insiders. Comparatively, 17.1% of Definitive Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Arqit Quantum has higher earnings, but lower revenue than Definitive Healthcare.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Arqit Quantum	$530K	826.24	-$35.34M	N/A	N/A
Definitive Healthcare	$241.52M	0.33	-$138.93M	-$1.62	N/A

Arqit Quantum has a net margin of 0.00% compared to Definitive Healthcare's net margin of -76.04%. Definitive Healthcare's return on equity of 4.04% beat Arqit Quantum's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Arqit Quantum	N/A	N/A	N/A
Definitive Healthcare	-76.04%	4.04%	1.99%

Summary

Definitive Healthcare beats Arqit Quantum on 7 of the 13 factors compared between the two stocks.

Get Definitive Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DH vs. The Competition

Export

Metric	Definitive Healthcare	INTERNET SOFTWARE Industry	Computer Sector	NASDAQ Exchange
Market Cap	$77.79M	$16.04B	$38.34B	$12.32B
Dividend Yield	N/A	3.63%	3.30%	5.88%
P/E Ratio	-0.47	59.45	169.72	23.96
Price / Sales	0.33	40.89	625.79	107.90
Price / Cash	0.37	68.61	46.62	53.76
Price / Book	0.29	6.20	9.51	6.41
Net Income	-$138.93M	$384.51M	$1.07B	$337.14M
7 Day Performance	-3.80%	-0.53%	0.36%	-0.48%
1 Month Performance	-10.82%	-4.32%	3.10%	0.49%
1 Year Performance	-81.00%	-10.91%	154.70%	28.16%

Definitive Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DH Definitive Healthcare	2.9748 of 5 stars	$0.76 +3.1%	$2.77 +264.0%	-81.4%	$77.79M	$241.52M	N/A	970	News Coverage
DUOT Duos Technologies Group	3.23 of 5 stars	$11.64 -4.8%	$22.00 +89.0%	+63.8%	$341.29M	$27.02M	N/A	70
TLS Telos	2.4033 of 5 stars	$4.54 +1.2%	$7.10 +56.6%	+72.9%	$339.31M	$164.80M	N/A	850	Insider Trade
PERI Perion Network	4.2339 of 5 stars	$8.62 +0.6%	$13.88 +61.1%	-7.4%	$336.24M	$439.93M	N/A	420	Positive News
ISSC Innovative Solutions and Support	2.5966 of 5 stars	$17.09 -3.3%	$16.25 -4.9%	+29.6%	$304.67M	$84.30M	18.12	80	News Coverage Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DH) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Definitive Healthcare (DH) Competitors

DH vs. DUOT, TLS, PERI, ISSC, and ARQQ

How does Definitive Healthcare compare to Duos Technologies Group?

Summary

How does Definitive Healthcare compare to Telos?

Summary

How does Definitive Healthcare compare to Perion Network?

Summary

How does Definitive Healthcare compare to Innovative Solutions and Support?

Summary

How does Definitive Healthcare compare to Arqit Quantum?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DH vs. The Competition

Definitive Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Definitive Healthcare (DH) Competitors

DH vs. DUOT, TLS, PERI, ISSC, and ARQQ

How does Definitive Healthcare compare to Duos Technologies Group?

Which has better earnings & valuation, DUOT or DH?

Does the media prefer DUOT or DH?

Is DUOT or DH more profitable?

Do analysts recommend DUOT or DH?

Do insiders & institutionals believe in DUOT or DH?

Which has more volatility & risk, DUOT or DH?

Summary

How does Definitive Healthcare compare to Telos?

Do analysts recommend TLS or DH?

Does the media prefer TLS or DH?

Which has preferable earnings & valuation, TLS or DH?

Is TLS or DH more profitable?

Do institutionals & insiders have more ownership in TLS or DH?

Which has more volatility and risk, TLS or DH?

Summary

How does Definitive Healthcare compare to Perion Network?

Which has more risk and volatility, DH or PERI?

Does the media favor DH or PERI?

Is DH or PERI more profitable?

Do insiders & institutionals hold more shares of DH or PERI?

Which has better valuation and earnings, DH or PERI?

Do analysts rate DH or PERI?

Summary

How does Definitive Healthcare compare to Innovative Solutions and Support?

Is DH or ISSC more profitable?

Which has more volatility & risk, DH or ISSC?

Do insiders & institutionals have more ownership in DH or ISSC?

Do analysts rate DH or ISSC?

Which has better earnings & valuation, DH or ISSC?

Does the media prefer DH or ISSC?

Summary

How does Definitive Healthcare compare to Arqit Quantum?

Which has more volatility & risk, ARQQ or DH?

Does the media prefer ARQQ or DH?

Do analysts prefer ARQQ or DH?

Do insiders and institutionals have more ownership in ARQQ or DH?

Which has better valuation and earnings, ARQQ or DH?

Is ARQQ or DH more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DH vs. The Competition

Definitive Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools